"Designing Growth Strategies is in our DNA"

Antiviral Drugs Market Size, Share & Industry Analysis, By Drug Class (Protease Inhibitors, Polymerase Inhibitors, Integrase Inhibitors, Combination Drugs, Reverse Transcriptase Inhibitors, and Others), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel) and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI102190

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Key Industry Trends
    2. Recent industry developments such as mergers & acquisitions
    3. regulatory and reimbursement scenario for key countries
    4. Prevalence of Key viral diseases, in major countries, 2018
    5. New Product Launches
  5. Global Antiviral Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Antiviral Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Antiviral Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Antiviral Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Antiviral Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Antiviral Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Gilead Sciences
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. GlaxoSmithKline
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Abbvie, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Merck & Co., Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Bristol-Myers Squibb Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Mylan N.V.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations

List of Figure:

Figure 1:  Global Antiviral Drugs Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Antiviral Drugs Market Value Share (%), by Drug Class, 2018 & 2026

Figure 3:  Global Antiviral Drugs Market Forecast (US$ Mn), by Integrase Inhibitors, 2015-2026

Figure 4:  Global Antiviral Drugs Market Forecast (US$ Mn), by Polymerase Inhibitors, 2015-2026

Figure 5:  Global Antiviral Drugs Market Forecast (US$ Mn), by Protease Inhibitors, 2015-2026

Figure 6:  Global Antiviral Drugs Market Forecast (US$ Mn), by Combination Drugs, 2015-2026

Figure 7:  Global Antiviral Drugs Market Forecast (US$ Mn), by Reverse Transcriptase Inhibitors, 2015-2026

Figure 8:  Global Antiviral Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 9:  Global Antiviral Drugs Market Value Share (%), by Disease Indication, 2018 & 2026

Figure 10:  Global Antiviral Drugs Market Forecast (US$ Mn), by Hepatitis, 2015-2026

Figure 11:  Global Antiviral Drugs Market Forecast (US$ Mn), by Human Immunodeficiency Virus (HIV), 2015-2026

Figure 12:  Global Antiviral Drugs Market Forecast (US$ Mn), by Influenza, 2015-2026

Figure 13:  Global Antiviral Drugs Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 14:  Global Antiviral Drugs Market Forecast (US$ Mn), by Hospital Pharmacy, 2015-2026

Figure 15:  Global Antiviral Drugs Market Forecast (US$ Mn), by Retail Pharmacy, 2015-2026

Figure 16:  Global Antiviral Drugs Market Forecast (US$ Mn), by Online Channel, 2015-2026

Figure 17:  Global Antiviral Drugs Market Value (US$ Mn), by Region, 2018 & 2026

Figure 18:  North America Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 19:  North America Antiviral Drugs Market Value Share (%), by Drug Class, 2018

Figure 20:  North America Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 21:  North America Antiviral Drugs Market Value Share (%), by Disease Indication, 2018

Figure 22:  North America Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 23:  North America Antiviral Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 24:  North America Antiviral Drugs Market Value (US$ Mn), By Country, 2018 & 2026

Figure 25:  North America Antiviral Drugs Market Value Share (%), By Country, 2018

Figure 26:  Europe Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 27:  Europe Antiviral Drugs Market Value Share (%), by Drug Class, 2018

Figure 28:  Europe Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 29:  Europe Antiviral Drugs Market Value Share (%), by Disease Indication, 2018

Figure 30:  Europe Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 31:  Europe Antiviral Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 32:  Europe Antiviral Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 33:  Europe Antiviral Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 34:  Asia Pacific Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 35:  Asia Pacific Antiviral Drugs Market Value Share (%), by Drug Class, 2018

Figure 36:  Asia Pacific Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 37:  Asia Pacific Antiviral Drugs Market Value Share (%), by Disease Indication, 2018

Figure 38:  Asia Pacific Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 39:  Asia Pacific Antiviral Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 40:  Asia Pacific Antiviral Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 41:  Asia Pacific Antiviral Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 42:  Latin America Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 43:  Latin America Antiviral Drugs Market Value Share (%), by Drug Class, 2018

Figure 44:  Latin America Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 45:  Latin America Antiviral Drugs Market Value Share (%), by Disease Indication, 2018

Figure 46:  Latin America Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 47:  Latin America Antiviral Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 48:  Latin America Antiviral Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 49:  Latin America Antiviral Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 50:  Middle East & Africa Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 51:  Middle East & Africa Antiviral Drugs Market Value Share (%), by Drug Class, 2018

Figure 52:  Middle East & Africa Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 53:  Middle East & Africa Antiviral Drugs Market Value Share (%), by Disease Indication, 2018

Figure 54:  Middle East & Africa Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 55:  Middle East & Africa Antiviral Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 56:  Middle East & Africa Antiviral Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 57:  Middle East & Africa Antiviral Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 58:  Global Antiviral Drugs Market Share (%), By Company, 2018

List of Table

Table 1:  Global Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2015–2026

Table 2:  Global Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015–2026

Table 3:  Global Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 6:  North America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 7:  North America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 10:  Europe Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 11:  Europe Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 14:  Asia Pacific Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 15:  Asia Pacific Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 18:  Latin America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 19:  Latin America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Latin America Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 22:  Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 23:  Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

 class=
  • Feb, 2020
  • 2018
  • 2015-2017
  • 130

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X